A Follow-Up Study of Straight and Tapered Dental Implants in the Front Upper Jaw
Condition(s) studied
Investigational drug(s) / intervention(s)
Neoss Implant System (ProActive Straight and Tapered): Participants will receive implant-supported crowns or bridges supported by Neoss dental implants (ProActive Straight and Tapered) placed in the anterior maxilla. Implant placement and prosthetic rehabilitation will be performed according to standard clinical procedures using a commercially available CE-marked implant system. The implants serve as support for fixed prosthetic restorations, and participants will be followed for 5 years to evaluate clinical, radiographic, and patient-reported outcomes.
Study summary
This prospective study aims to evaluate 5-year clinical, radiographic, and patient-reported outcomes of implant-supported crowns and bridges placed on Neoss implants (ProActive Straight and Tapered) in the anterior maxilla (region 13 - 23). The study is conducted at Brånemarkkliniken, Public Dental Service, Västra Götalandsregionen, Sweden. While the treatment involves established methods and CE-marked devices, long-term data for this specific indication are limited.
Eligibility
Primary outcome measure(s)
- Implant Survival — Baseline, 1 year, and 5 years
Absence of implant loss during the study period. - Change in marginal bone level around implants — Baseline, 1 year, and 5 years
Change in marginal bone level around implants as assessed by radiographic evaluation using standardized, anonymized radiographs. Measurements will be performed by an independent examiner.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden | Gothenburg | Sweden |
More Branemarkkliniken trials in Sweden
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07544706 on ClinicalTrials.gov ↗ ← All trials in Sweden